Richard Newitter
Stock Analyst at Truist Securities
(4.42)
# 278
Out of 4,853 analysts
362
Total ratings
54.88%
Success rate
16.17%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Hold | $80 → $68 | $59.71 | +13.88% | 27 | May 12, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $127 → $117 | $80.83 | +44.75% | 18 | May 8, 2025 | |
| TFX Teleflex | Maintains: Hold | $140 → $137 | $122.45 | +11.88% | 38 | May 5, 2025 | |
| SYK Stryker | Maintains: Hold | $390 → $400 | $384.04 | +4.16% | 20 | May 5, 2025 | |
| GKOS Glaukos | Reiterates: Buy | $140 → $135 | $93.41 | +44.52% | 5 | May 1, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $140 → $150 | $121.15 | +23.81% | 7 | Apr 28, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $113 → $117 | $102.08 | +14.62% | 12 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $605 → $590 | $556.40 | +6.04% | 28 | Apr 23, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $90 → $70 | $64.00 | +9.38% | 14 | Apr 11, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $51 | $43.26 | +17.91% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $8 | $5.79 | +38.17% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $87.32 | +3.07% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $21.24 | +13.02% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $13.60 | +39.71% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $78 → $75 | $77.56 | -3.30% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $145.71 | -0.49% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $235 | $135.58 | +73.33% | 24 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $92.35 | +22.36% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $257.94 | +10.49% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $18.80 | +11.70% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $15.06 | +32.80% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $87.77 | -6.57% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $172.96 | +44.54% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.07 | +746.91% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $180.36 | +326.92% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $64.57 | +31.64% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.08 | +52.91% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $10.95 | +146.58% | 5 | Feb 23, 2021 |
Globus Medical
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $59.71
Upside: +13.88%
Lantheus Holdings
May 8, 2025
Maintains: Buy
Price Target: $127 → $117
Current: $80.83
Upside: +44.75%
Teleflex
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $122.45
Upside: +11.88%
Stryker
May 5, 2025
Maintains: Hold
Price Target: $390 → $400
Current: $384.04
Upside: +4.16%
Glaukos
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $93.41
Upside: +44.52%
Integer Holdings
Apr 28, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $121.15
Upside: +23.81%
Boston Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $113 → $117
Current: $102.08
Upside: +14.62%
Intuitive Surgical
Apr 23, 2025
Maintains: Buy
Price Target: $605 → $590
Current: $556.40
Upside: +6.04%
PROCEPT BioRobotics
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $64.00
Upside: +9.38%
Vericel
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $43.26
Upside: +17.91%
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $5.79
Upside: +38.17%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $87.32
Upside: +3.07%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $21.24
Upside: +13.02%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $13.60
Upside: +39.71%
Apr 11, 2025
Maintains: Hold
Price Target: $78 → $75
Current: $77.56
Upside: -3.30%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $145.71
Upside: -0.49%
Feb 11, 2025
Maintains: Buy
Price Target: $250 → $235
Current: $135.58
Upside: +73.33%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $92.35
Upside: +22.36%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $257.94
Upside: +10.49%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $18.80
Upside: +11.70%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $15.06
Upside: +32.80%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $87.77
Upside: -6.57%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $172.96
Upside: +44.54%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.07
Upside: +746.91%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $180.36
Upside: +326.92%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $64.57
Upside: +31.64%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.08
Upside: +52.91%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $10.95
Upside: +146.58%